 | • レポートコード：QY2108PAL8870 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるVRE・MRSA抗生物質の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、VRE・MRSA抗生物質の種類別市場規模（バンコマイシン、テイコプラニン、リネゾリド、ダプトマイシン、その他）、用途別市場規模（病院、クリニック、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のVRE・MRSA抗生物質市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるVRE・MRSA抗生物質の種類別市場規模（2016年-2027年）：バンコマイシン、テイコプラニン、リネゾリド、ダプトマイシン、その他 ・世界におけるVRE・MRSA抗生物質の用途別市場規模（2016年-2027年）：病院、クリニック、その他 ・VRE・MRSA抗生物質の中国市場分析 - VRE・MRSA抗生物質の中国市場規模（2016年-2027年） - 中国におけるVRE・MRSA抗生物質の主要プレイヤー別市場シェア - 中国におけるVRE・MRSA抗生物質の種類別市場規模：バンコマイシン、テイコプラニン、リネゾリド、ダプトマイシン、その他 - 中国におけるVRE・MRSA抗生物質の用途別市場規模：病院、クリニック、その他 ・VRE・MRSA抗生物質の北米市場（2016年-2027年） ・VRE・MRSA抗生物質のヨーロッパ市場（2016年-2027年） ・VRE・MRSA抗生物質のアジア太平洋市場（2016年-2027年） ・VRE・MRSA抗生物質の中南米市場（2016年-2027年） ・VRE・MRSA抗生物質の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Pfizer、Lilly、Sanofi Aventis、Merck、Fresenius Kabi、Xellia Pharmaceuticals (Novo Holdings)、Zhejiang Medicine、Zhejiang Hisun Pharmaceutical、North China Pharmaceutical、Korea United Pharm ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread by contact and can cause serious infections. MRSA can be spread by touching articles that have been contaminated by the skin of an infected or colonized person, such as towels, sheets, and wound dressings; VRE can be transmitted by touching articles soiled by an infected person’s feces. Both of these bacteria survive well on hands and for weeks on inanimate objects. Colonization occurs when bacteria are present on or in the body (i.e., nose, skin, rectum, moist areas of the body and the newborn’s umbilicus) without causing illness.
An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention of such infections. They may either kill or inhibit the growth of bacteria.
The market for is VRE and MRSA Antibiotic market fragmented with players such as Pfizer, Lilly, Sanofi Aventis, Merck, Fresenius Kabi, Xellia Pharmaceuticals (Novo Holdings), Zhejiang Medicine, Zhejiang Hisun Pharmaceutical, North China Pharmaceutical. Among the companies, pfizer contributed 16% of the market, which is the biggest in 2019.
Category, included in this market are Teicoplanin, Vancomycin, Linezolid, Daptomycin, Others. The Linezolid contributed most in the revenue of the VRE and MRSA Antibiotic，which is 38% of the market.
The application for VRE and MRSA Antibiotic market is segment with application such as hospitals, clinics and others, in 2020, the sales in the hospitals is the biggest, occupies almost 2/3 of the market.
As for the regional market share, the Americas is expected to hold the largest share of the global MRSA drugs market.
Market Analysis and Insights: Global and China VRE and MRSA Antibiotic Market
This report focuses on global and China VRE and MRSA Antibiotic market.
In 2020, the global VRE and MRSA Antibiotic market size was US$ 3886.2 million and it is expected to reach US$ 5369 million by the end of 2027, with a CAGR of 4.7% during 2021-2027. In China the VRE and MRSA Antibiotic market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global VRE and MRSA Antibiotic Scope and Market Size
VRE and MRSA Antibiotic market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global VRE and MRSA Antibiotic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the VRE and MRSA Antibiotic market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Vancomycin
Teicoplanin
Linezolid
Daptomycin
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
Lilly
Sanofi Aventis
Merck
Fresenius Kabi
Xellia Pharmaceuticals (Novo Holdings)
Zhejiang Medicine
Zhejiang Hisun Pharmaceutical
North China Pharmaceutical
Korea United Pharm
1 Study Coverage
1.1 VRE and MRSA Antibiotic Product Introduction
1.2 Market by Type
1.2.1 Global VRE and MRSA Antibiotic Market Size Growth Rate by Type
1.2.2 Vancomycin
1.2.3 Teicoplanin
1.2.4 Linezolid
1.2.5 Daptomycin
1.2.6 Others
1.3 Market by Application
1.3.1 Global VRE and MRSA Antibiotic Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global VRE and MRSA Antibiotic Market Size, Estimates and Forecasts
2.1.1 Global VRE and MRSA Antibiotic Revenue 2016-2027
2.1.2 Global VRE and MRSA Antibiotic Sales 2016-2027
2.2 Global VRE and MRSA Antibiotic, Market Size by Region: 2016 VS 2021 VS 2027
2.3 VRE and MRSA Antibiotic Historical Market Size by Region (2016-2021)
2.3.1 Global VRE and MRSA Antibiotic Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global VRE and MRSA Antibiotic Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 VRE and MRSA Antibiotic Market Estimates and Projections by Region (2022-2027)
2.4.1 Global VRE and MRSA Antibiotic Sales Forecast by Region (2022-2027)
2.4.2 Global VRE and MRSA Antibiotic Revenue Forecast by Region (2022-2027)
3 Global VRE and MRSA Antibiotic Competitor Landscape by Players
3.1 Global Top VRE and MRSA Antibiotic Manufacturers by Sales
3.1.1 Global VRE and MRSA Antibiotic Sales by Manufacturer (2016-2021)
3.1.2 Global VRE and MRSA Antibiotic Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top VRE and MRSA Antibiotic Manufacturers by Revenue
3.2.1 Key VRE and MRSA Antibiotic Manufacturers Covered: Ranking by Revenue
3.2.2 Global VRE and MRSA Antibiotic Revenue by Manufacturers (2016-2021)
3.2.3 Global VRE and MRSA Antibiotic Revenue Share by Manufacturers (2016-2021)
3.2.4 Global VRE and MRSA Antibiotic Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by VRE and MRSA Antibiotic Revenue in 2020
3.2.6 Global VRE and MRSA Antibiotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global VRE and MRSA Antibiotic Price by Manufacturers
3.4 Global VRE and MRSA Antibiotic Manufacturing Base Distribution, Product Types
3.4.1 VRE and MRSA Antibiotic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers VRE and MRSA Antibiotic Product Type
3.4.3 Date of International Manufacturers Enter into VRE and MRSA Antibiotic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global VRE and MRSA Antibiotic Market Size by Type (2016-2021)
4.1.1 Global VRE and MRSA Antibiotic Sales by Type (2016-2021)
4.1.2 Global VRE and MRSA Antibiotic Revenue by Type (2016-2021)
4.1.3 VRE and MRSA Antibiotic Average Selling Price (ASP) by Type (2016-2021)
4.2 Global VRE and MRSA Antibiotic Market Size Forecast by Type (2022-2027)
4.2.1 Global VRE and MRSA Antibiotic Sales Forecast by Type (2022-2027)
4.2.2 Global VRE and MRSA Antibiotic Revenue Forecast by Type (2022-2027)
4.2.3 VRE and MRSA Antibiotic Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global VRE and MRSA Antibiotic Market Size by Application (2016-2021)
5.1.1 Global VRE and MRSA Antibiotic Sales by Application (2016-2021)
5.1.2 Global VRE and MRSA Antibiotic Revenue by Application (2016-2021)
5.1.3 VRE and MRSA Antibiotic Price by Application (2016-2021)
5.2 VRE and MRSA Antibiotic Market Size Forecast by Application (2022-2027)
5.2.1 Global VRE and MRSA Antibiotic Sales Forecast by Application (2022-2027)
5.2.2 Global VRE and MRSA Antibiotic Revenue Forecast by Application (2022-2027)
5.2.3 Global VRE and MRSA Antibiotic Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China VRE and MRSA Antibiotic Market Size YoY Growth 2016-2027
6.1.1 China VRE and MRSA Antibiotic Sales YoY Growth 2016-2027
6.1.2 China VRE and MRSA Antibiotic Revenue YoY Growth 2016-2027
6.1.3 China VRE and MRSA Antibiotic Market Share in Global Market 2016-2027
6.2 China VRE and MRSA Antibiotic Market Size by Players (International and Local Players)
6.2.1 China Top VRE and MRSA Antibiotic Players by Sales (2016-2021)
6.2.2 China Top VRE and MRSA Antibiotic Players by Revenue (2016-2021)
6.3 China VRE and MRSA Antibiotic Historic Market Review by Type (2016-2021)
6.3.1 China VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
6.3.2 China VRE and MRSA Antibiotic Revenue Market Share by Type (2016-2021)
6.3.3 China VRE and MRSA Antibiotic Price by Type (2016-2021)
6.4 China VRE and MRSA Antibiotic Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China VRE and MRSA Antibiotic Sales Forecast by Type (2022-2027)
6.4.2 China VRE and MRSA Antibiotic Revenue Forecast by Type (2022-2027)
6.4.3 China VRE and MRSA Antibiotic Price Forecast by Type (2022-2027)
6.5 China VRE and MRSA Antibiotic Historic Market Review by Application (2016-2021)
6.5.1 China VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
6.5.2 China VRE and MRSA Antibiotic Revenue Market Share by Application (2016-2021)
6.5.3 China VRE and MRSA Antibiotic Price by Application (2016-2021)
6.6 China VRE and MRSA Antibiotic Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China VRE and MRSA Antibiotic Sales Forecast by Application (2022-2027)
6.6.2 China VRE and MRSA Antibiotic Revenue Forecast by Application (2022-2027)
6.6.3 China VRE and MRSA Antibiotic Price Forecast by Application (2022-2027)
7 North America
7.1 North America VRE and MRSA Antibiotic Market Size YoY Growth 2016-2027
7.2 North America VRE and MRSA Antibiotic Market Facts & Figures by Country
7.2.1 North America VRE and MRSA Antibiotic Sales by Country (2016-2021)
7.2.2 North America VRE and MRSA Antibiotic Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific VRE and MRSA Antibiotic Market Size YoY Growth 2016-2027
8.2 Asia Pacific VRE and MRSA Antibiotic Market Facts & Figures by Region
8.2.1 Asia Pacific VRE and MRSA Antibiotic Sales by Region (2016-2021)
8.2.2 Asia Pacific VRE and MRSA Antibiotic Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe VRE and MRSA Antibiotic Market Size YoY Growth 2016-2027
9.2 Europe VRE and MRSA Antibiotic Market Facts & Figures by Country
9.2.1 Europe VRE and MRSA Antibiotic Sales by Country (2016-2021)
9.2.2 Europe VRE and MRSA Antibiotic Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America VRE and MRSA Antibiotic Market Size YoY Growth 2016-2027
10.2 Latin America VRE and MRSA Antibiotic Market Facts & Figures by Country
10.2.1 Latin America VRE and MRSA Antibiotic Sales by Country (2016-2021)
10.2.2 Latin America VRE and MRSA Antibiotic Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa VRE and MRSA Antibiotic Market Size YoY Growth 2016-2027
11.2 Middle East and Africa VRE and MRSA Antibiotic Market Facts & Figures by Country
11.2.1 Middle East and Africa VRE and MRSA Antibiotic Sales by Country (2016-2021)
11.2.2 Middle East and Africa VRE and MRSA Antibiotic Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer VRE and MRSA Antibiotic Products Offered
12.1.5 Pfizer Recent Development
12.2 Lilly
12.2.1 Lilly Corporation Information
12.2.2 Lilly Description and Business Overview
12.2.3 Lilly VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Lilly VRE and MRSA Antibiotic Products Offered
12.2.5 Lilly Recent Development
12.3 Sanofi Aventis
12.3.1 Sanofi Aventis Corporation Information
12.3.2 Sanofi Aventis Description and Business Overview
12.3.3 Sanofi Aventis VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Aventis VRE and MRSA Antibiotic Products Offered
12.3.5 Sanofi Aventis Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck VRE and MRSA Antibiotic Products Offered
12.4.5 Merck Recent Development
12.5 Fresenius Kabi
12.5.1 Fresenius Kabi Corporation Information
12.5.2 Fresenius Kabi Description and Business Overview
12.5.3 Fresenius Kabi VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Fresenius Kabi VRE and MRSA Antibiotic Products Offered
12.5.5 Fresenius Kabi Recent Development
12.6 Xellia Pharmaceuticals (Novo Holdings)
12.6.1 Xellia Pharmaceuticals (Novo Holdings) Corporation Information
12.6.2 Xellia Pharmaceuticals (Novo Holdings) Description and Business Overview
12.6.3 Xellia Pharmaceuticals (Novo Holdings) VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Xellia Pharmaceuticals (Novo Holdings) VRE and MRSA Antibiotic Products Offered
12.6.5 Xellia Pharmaceuticals (Novo Holdings) Recent Development
12.7 Zhejiang Medicine
12.7.1 Zhejiang Medicine Corporation Information
12.7.2 Zhejiang Medicine Description and Business Overview
12.7.3 Zhejiang Medicine VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Zhejiang Medicine VRE and MRSA Antibiotic Products Offered
12.7.5 Zhejiang Medicine Recent Development
12.8 Zhejiang Hisun Pharmaceutical
12.8.1 Zhejiang Hisun Pharmaceutical Corporation Information
12.8.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
12.8.3 Zhejiang Hisun Pharmaceutical VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zhejiang Hisun Pharmaceutical VRE and MRSA Antibiotic Products Offered
12.8.5 Zhejiang Hisun Pharmaceutical Recent Development
12.9 North China Pharmaceutical
12.9.1 North China Pharmaceutical Corporation Information
12.9.2 North China Pharmaceutical Description and Business Overview
12.9.3 North China Pharmaceutical VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.9.4 North China Pharmaceutical VRE and MRSA Antibiotic Products Offered
12.9.5 North China Pharmaceutical Recent Development
12.10 Korea United Pharm
12.10.1 Korea United Pharm Corporation Information
12.10.2 Korea United Pharm Description and Business Overview
12.10.3 Korea United Pharm VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Korea United Pharm VRE and MRSA Antibiotic Products Offered
12.10.5 Korea United Pharm Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer VRE and MRSA Antibiotic Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer VRE and MRSA Antibiotic Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 VRE and MRSA Antibiotic Industry Trends
13.2 VRE and MRSA Antibiotic Market Drivers
13.3 VRE and MRSA Antibiotic Market Challenges
13.4 VRE and MRSA Antibiotic Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 VRE and MRSA Antibiotic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global VRE and MRSA Antibiotic Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Vancomycin
Table 3. Major Manufacturers of Teicoplanin
Table 4. Major Manufacturers of Linezolid
Table 5. Major Manufacturers of Daptomycin
Table 6. Major Manufacturers of Others
Table 7. Global VRE and MRSA Antibiotic Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 8. Global VRE and MRSA Antibiotic Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global VRE and MRSA Antibiotic Sales by Regions (2016-2021) & (M Units)
Table 10. Global VRE and MRSA Antibiotic Sales Market Share by Regions (2016-2021)
Table 11. Global VRE and MRSA Antibiotic Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global VRE and MRSA Antibiotic Sales Forecast by Region (2022-2027) & (M Units)
Table 13. Global VRE and MRSA Antibiotic Sales Market Share Forecast by Region (2022-2027)
Table 14. Global VRE and MRSA Antibiotic Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global VRE and MRSA Antibiotic Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global VRE and MRSA Antibiotic Sales by Manufacturers (2016-2021) (M Units)
Table 17. Global VRE and MRSA Antibiotic Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top VRE and MRSA Antibiotic Manufacturers by Revenue (US$ Million) in 2020
Table 19. VRE and MRSA Antibiotic Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. VRE and MRSA Antibiotic Revenue Share by Manufacturers (2016-2021)
Table 21. Global VRE and MRSA Antibiotic Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global VRE and MRSA Antibiotic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in VRE and MRSA Antibiotic as of 2020)
Table 23. Key Manufacturers VRE and MRSA Antibiotic Price (2016-2021) (USD/Unit)
Table 24. VRE and MRSA Antibiotic Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers VRE and MRSA Antibiotic Product Type
Table 26. Date of International Manufacturers Enter into VRE and MRSA Antibiotic Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global VRE and MRSA Antibiotic Sales by Type (2016-2021) (M Units)
Table 29. Global VRE and MRSA Antibiotic Sales Share by Type (2016-2021)
Table 30. Global VRE and MRSA Antibiotic Revenue by Type (2016-2021) (US$ Million)
Table 31. Global VRE and MRSA Antibiotic Revenue Share by Type (2016-2021)
Table 32. VRE and MRSA Antibiotic Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 33. Global VRE and MRSA Antibiotic Sales Forecast by Type (2022-2027) & (M Units)
Table 34. Global VRE and MRSA Antibiotic Sales Market Share Forecast by Type (2022-2027)
Table 35. Global VRE and MRSA Antibiotic Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global VRE and MRSA Antibiotic Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global VRE and MRSA Antibiotic Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global VRE and MRSA Antibiotic Sales by Application (2016-2021) (M Units)
Table 39. Global VRE and MRSA Antibiotic Sales Share by Application (2016-2021)
Table 40. Global VRE and MRSA Antibiotic Revenue by Application (2016-2021) (US$ Million)
Table 41. Global VRE and MRSA Antibiotic Revenue Share by Application (2016-2021)
Table 42. VRE and MRSA Antibiotic Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 43. Global VRE and MRSA Antibiotic Sales Forecast by Application (2022-2027) & (M Units)
Table 44. Global VRE and MRSA Antibiotic Sales Market Share Forecast by Application (2022-2027)
Table 45. Global VRE and MRSA Antibiotic Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global VRE and MRSA Antibiotic Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global VRE and MRSA Antibiotic Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 48. China VRE and MRSA Antibiotic Sales (M Units) of Key Companies (2016-2021)
Table 49. China VRE and MRSA Antibiotic Sales Share by Company (2016-2021)
Table 50. China VRE and MRSA Antibiotic Revenue (US$ Million) by Company (2016-2021)
Table 51. China VRE and MRSA Antibiotic Revenue Share by Company (2016-2021)
Table 52. China VRE and MRSA Antibiotic Sales (M Units) by Type (2016-2021)
Table 53. China VRE and MRSA Antibiotic Sales Share by Type (2016-2021)
Table 54. China VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China VRE and MRSA Antibiotic Price (USD/Unit) by Type (2016-2021)
Table 56. China VRE and MRSA Antibiotic Sales (M Units) by Type (2022-2027)
Table 57. China VRE and MRSA Antibiotic Sales Share by Type (2022-2027)
Table 58. China VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China VRE and MRSA Antibiotic Revenue Share by Type (2022-2027)
Table 60. China VRE and MRSA Antibiotic Price (USD/Unit) by Type (2022-2027)
Table 61. China VRE and MRSA Antibiotic Sales (M Units) by Application (2016-2021)
Table 62. China VRE and MRSA Antibiotic Sales Share by Application (2016-2021)
Table 63. China VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China VRE and MRSA Antibiotic Price (USD/Unit) by Application (2016-2021)
Table 65. China VRE and MRSA Antibiotic Sales (M Units) by Application (2022-2027)
Table 66. China VRE and MRSA Antibiotic Sales Share by Application (2022-2027)
Table 67. China VRE and MRSA Antibiotic Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China VRE and MRSA Antibiotic Revenue Share by Application (2022-2027)
Table 69. China VRE and MRSA Antibiotic Price (USD/Unit) by Application (2022-2027)
Table 70. North America VRE and MRSA Antibiotic Sales by Country (2016-2021) & (M Units)
Table 71. North America VRE and MRSA Antibiotic Sales Market Share by Country (2016-2021)
Table 72. North America VRE and MRSA Antibiotic Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America VRE and MRSA Antibiotic Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific VRE and MRSA Antibiotic Sales by Region (2016-2021) & (M Units)
Table 75. Asia Pacific VRE and MRSA Antibiotic Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific VRE and MRSA Antibiotic Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific VRE and MRSA Antibiotic Revenue Market Share by Region (2016-2021)
Table 78. Europe VRE and MRSA Antibiotic Sales by Country (2016-2021) & (M Units)
Table 79. Europe VRE and MRSA Antibiotic Sales Market Share by Country (2016-2021)
Table 80. Europe VRE and MRSA Antibiotic Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe VRE and MRSA Antibiotic Revenue Market Share by Country (2016-2021)
Table 82. Latin America VRE and MRSA Antibiotic Sales by Country (2016-2021) & (M Units)
Table 83. Latin America VRE and MRSA Antibiotic Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa VRE and MRSA Antibiotic Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America VRE and MRSA Antibiotic Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa VRE and MRSA Antibiotic Sales by Country (2016-2021) & (M Units)
Table 87. Middle East and Africa VRE and MRSA Antibiotic Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa VRE and MRSA Antibiotic Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa VRE and MRSA Antibiotic Revenue Market Share by Country (2016-2021)
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 93. Pfizer VRE and MRSA Antibiotic Product
Table 94. Pfizer Recent Development
Table 95. Lilly Corporation Information
Table 96. Lilly Description and Business Overview
Table 97. Lilly VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 98. Lilly Product
Table 99. Lilly Recent Development
Table 100. Sanofi Aventis Corporation Information
Table 101. Sanofi Aventis Description and Business Overview
Table 102. Sanofi Aventis VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Sanofi Aventis Product
Table 104. Sanofi Aventis Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Merck Product
Table 109. Merck Recent Development
Table 110. Fresenius Kabi Corporation Information
Table 111. Fresenius Kabi Description and Business Overview
Table 112. Fresenius Kabi VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Fresenius Kabi Product
Table 114. Fresenius Kabi Recent Development
Table 115. Xellia Pharmaceuticals (Novo Holdings) Corporation Information
Table 116. Xellia Pharmaceuticals (Novo Holdings) Description and Business Overview
Table 117. Xellia Pharmaceuticals (Novo Holdings) VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Xellia Pharmaceuticals (Novo Holdings) Product
Table 119. Xellia Pharmaceuticals (Novo Holdings) Recent Development
Table 120. Zhejiang Medicine Corporation Information
Table 121. Zhejiang Medicine Description and Business Overview
Table 122. Zhejiang Medicine VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Zhejiang Medicine Product
Table 124. Zhejiang Medicine Recent Development
Table 125. Zhejiang Hisun Pharmaceutical Corporation Information
Table 126. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 127. Zhejiang Hisun Pharmaceutical VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Zhejiang Hisun Pharmaceutical Product
Table 129. Zhejiang Hisun Pharmaceutical Recent Development
Table 130. North China Pharmaceutical Corporation Information
Table 131. North China Pharmaceutical Description and Business Overview
Table 132. North China Pharmaceutical VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. North China Pharmaceutical Product
Table 134. North China Pharmaceutical Recent Development
Table 135. Korea United Pharm Corporation Information
Table 136. Korea United Pharm Description and Business Overview
Table 137. Korea United Pharm VRE and MRSA Antibiotic Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Korea United Pharm Product
Table 139. Korea United Pharm Recent Development
Table 140. VRE and MRSA Antibiotic Market Trends
Table 141. VRE and MRSA Antibiotic Market Drivers
Table 142. VRE and MRSA Antibiotic Market Challenges
Table 143. VRE and MRSA Antibiotic Market Restraints
Table 144. VRE and MRSA Antibiotic Customers List
Table 145. VRE and MRSA Antibiotic Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. VRE and MRSA Antibiotic Product Picture
Figure 2. Global VRE and MRSA Antibiotic Sales Market Share by Type in 2020 & 2027
Figure 3. Vancomycin Product Picture
Figure 4. Teicoplanin Product Picture
Figure 5. Linezolid Product Picture
Figure 6. Daptomycin Product Picture
Figure 7. Others Product Picture
Figure 8. Global VRE and MRSA Antibiotic Sales Market Share by Application in 2020 & 2027
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. VRE and MRSA Antibiotic Report Years Considered
Figure 13. Global VRE and MRSA Antibiotic Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global VRE and MRSA Antibiotic Market Size 2016-2027 (US$ Million)
Figure 15. Global VRE and MRSA Antibiotic Sales 2016-2027 (M Units)
Figure 16. Global VRE and MRSA Antibiotic Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global VRE and MRSA Antibiotic Sales Market Share by Region (2016-2021)
Figure 18. Global VRE and MRSA Antibiotic Sales Market Share by Region in 2020
Figure 19. Global VRE and MRSA Antibiotic Revenue Market Share by Region (2016-2021)
Figure 20. Global VRE and MRSA Antibiotic Revenue Market Share by Region in 2020
Figure 21. Global VRE and MRSA Antibiotic Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by VRE and MRSA Antibiotic Revenue in 2020
Figure 23. VRE and MRSA Antibiotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global VRE and MRSA Antibiotic Sales Market Share by Type (2016-2021)
Figure 25. Global VRE and MRSA Antibiotic Sales Market Share by Type in 2020
Figure 26. Global VRE and MRSA Antibiotic Revenue Market Share by Type (2016-2021)
Figure 27. Global VRE and MRSA Antibiotic Revenue Market Share by Type in 2020
Figure 28. Global VRE and MRSA Antibiotic Sales Market Share by Application (2016-2021)
Figure 29. Global VRE and MRSA Antibiotic Sales Market Share by Application in 2020
Figure 30. Global VRE and MRSA Antibiotic Revenue Market Share by Application (2016-2021)
Figure 31. Global VRE and MRSA Antibiotic Revenue Market Share by Application in 2020
Figure 32. China VRE and MRSA Antibiotic Sales Growth Rate 2016-2027 (M Units)
Figure 33. China VRE and MRSA Antibiotic Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China VRE and MRSA Antibiotic Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest VRE and MRSA Antibiotic Players Market Share by Revenue in VRE and MRSA Antibiotic in 2020
Figure 36. China VRE and MRSA Antibiotic Revenue Share by Type (2016-2021)
Figure 37. China VRE and MRSA Antibiotic Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China VRE and MRSA Antibiotic Revenue Share by Application (2016-2021)
Figure 39. China VRE and MRSA Antibiotic Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America VRE and MRSA Antibiotic Sales Growth Rate 2016-2021 (M Units)
Figure 41. North America VRE and MRSA Antibiotic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America VRE and MRSA Antibiotic Sales Market Share by Country in 2020
Figure 43. North America VRE and MRSA Antibiotic Revenue Market Share by Country in 2020
Figure 44. U.S. VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 45. U.S. VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 47. Canada VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe VRE and MRSA Antibiotic Sales Growth Rate 2016-2021 (M Units)
Figure 49. Europe VRE and MRSA Antibiotic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe VRE and MRSA Antibiotic Sales Market Share by Country in 2020
Figure 51. Europe VRE and MRSA Antibiotic Revenue Market Share by Country in 2020
Figure 52. Germany VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 53. Germany VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 55. France VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 57. U.K. VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 59. Italy VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 61. Russia VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific VRE and MRSA Antibiotic Sales Growth Rate 2016-2021 (M Units)
Figure 63. Asia Pacific VRE and MRSA Antibiotic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific VRE and MRSA Antibiotic Sales Market Share by Region in 2020
Figure 65. Asia Pacific VRE and MRSA Antibiotic Revenue Market Share by Region in 2020
Figure 66. China VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 67. China VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 69. Japan VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 71. South Korea VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 73. India VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 75. Australia VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Taiwan VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 77. Taiwan VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 79. Indonesia VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 81. Thailand VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 83. Malaysia VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Philippines VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 85. Philippines VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Vietnam VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 87. Vietnam VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Latin America VRE and MRSA Antibiotic Sales Growth Rate 2016-2021 (M Units)
Figure 89. Latin America VRE and MRSA Antibiotic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 90. Latin America VRE and MRSA Antibiotic Sales Market Share by Country in 2020
Figure 91. Latin America VRE and MRSA Antibiotic Revenue Market Share by Country in 2020
Figure 92. Mexico VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 93. Mexico VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Brazil VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 95. Brazil VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Argentina VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 97. Argentina VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Middle East and Africa VRE and MRSA Antibiotic Sales Growth Rate 2016-2021 (M Units)
Figure 99. Middle East and Africa VRE and MRSA Antibiotic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Middle East and Africa VRE and MRSA Antibiotic Sales Market Share by Country in 2020
Figure 101. Middle East and Africa VRE and MRSA Antibiotic Revenue Market Share by Country in 2020
Figure 102. Turkey VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 103. Turkey VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Saudi Arabia VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 105. Saudi Arabia VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. UAE VRE and MRSA Antibiotic Sales Growth Rate (2016-2021) (M Units)
Figure 107. UAE VRE and MRSA Antibiotic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. VRE and MRSA Antibiotic Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
市中感染型MRSA(CA-MRSA) 治療薬の世界市場 2020年 Market Overview The global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, …- 抗生物質APIの世界及び中国市場 Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used…
- 喉頭蓋炎治療薬の世界市場 2020年 Market Overview The global Epiglottitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Epiglottitis Drug market re…
- 鼻血治療薬の世界市場 2020年 Market Overview The global Epistaxis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Epistaxis Drugs market report…
- バンコマイシン耐性腸球菌フェシウム治療薬の世界市場 2020年 Market Overview The global Drugs for Vancomycin-Resistant Enterococcus Faecium market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…